Steven Michael Oliveira

This profile gathers the share dealings of Steven Michael Oliveira across 3 companies, led by IGC Pharma, Inc., Benitec Biopharma Inc. and Forte Biosciences, Inc. The record holds 19 filings, for trades running from 7 March 2008 to 9 December 2021.

Both buying and selling appear: 9 purchases worth €1.4M, against 8 sales worth €1.6M. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2021 alone, the filings show 6 purchases and no sales.

Half of the purchases are above €105k and half below. Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -28.3%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 9 December 2021, the filings show an open-market purchase worth €104k in Benitec Biopharma Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.